RCM Technologies, Inc. Announces Fourth Quarter and Full

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RCM Technologies, Inc. Announces Fourth Quarter and Full Year 2013 Results

PENNSAUKEN, N.J., Feb. 26, 2014 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (Nasdaq: RCMT ), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology, engineering and specialty health care services, today announced financial results for the thirteen and fifty-two week periods ended December 28, 2013.

The Company announced revenues of $45.8 million for the thirteen week period ended December 28, 2013, increased from $37.0 million for the thirteen week period ended December 29, 2012 (comparable prior year period), an increase of 23.9%. The Company had an operating loss of $2.5 million for the thirteen week period ended December 28, 2013 as compared to operating income of $1.3 million for the comparable prior year period. The Company had a net loss for the thirteen week period ended December 28, 2013 of $1.6 million, or $0.13 per diluted share, as compared to net income of $1.0 million, or $0.09 per diluted share, for the comparable prior year period.

The Company announced revenues of $170.8 million for the fifty-two week period ended December 28, 2013, increased from $145.8 million for the fifty-two week period ended December 29, 2012 (comparable prior year period), an increase of 17.1%. The Company had operating income of $2.6 million for the fifty-two week period ended December 28, 2013 as compared to $5.2 million for the comparable prior year period, a decrease of 51.1%. Net income for the fifty-two week period ended December 28, 2013 was $2.0 million, or $0.16 per diluted share, as compared to net income of $3.2 million, or $0.26 per diluted share, for the comparable prior year period, a decrease of 38.3%.

The Company recognized $4.7 million and $5.2 million in severance and other charges for the thirteen and fifty-two weeks ended December 28, 2013, respectively, as compared to zero for the comparable prior year periods. The thirteen weeks ended December 28, 2013 included $2.9 million related to the retirement of Leon Kopyt, the Company's President and Chief Executive Officer, $1.5 million related to the proxy contest leading to the Company's December 5, 2013 stockholder meeting, $0.1 million in facilities consolidation charges and $0.2 million in professional fees related to a research and development tax credit study. The fifty-two weeks ended December 28, 2013 included $2.9 million related to the retirement of Leon Kopyt, the Company's President and Chief Executive Officer, $1.6 million related to the proxy contest leading to the Company's December 5, 2013 stockholder meeting, $0.5 million in facilities consolidation charges and $0.2 million in professional fees related to a research and development tax credit study.

The fifty-two week period ended December 28, 2013 reflects an increase to net income of $0.5 million, or $0.04 per diluted share, resulting from the reduction of a previously unrecognized tax benefit.

Leon Kopyt, Chairman and CEO of RCM, commented: "We are pleased to report our highest quarterly revenues since the start of the Great Recession in the fourth quarter of fiscal 2008. Our Engineering segment experienced its highest quarterly revenue and second highest gross profit (trailing only the third quarter of 2013) in RCM's history. Our Specialty Healthcare segment experienced its highest quarterly revenues and gross profit in RCM's history. Our Information Technology segment continued its upward trend by posting its highest quarterly revenue and gross profit since the first quarter of fiscal 2011. By way of comparing the fourth quarter of fiscal 2013 to the fourth quarter of 2012, Engineering grew revenues and gross profit 29.7% and 12.5%, respectively, Information Technology grew revenues and gross profit 9.8% and 14.2%, respectively, and Specialty Healthcare grew revenues and gross profit 35.3% and 31.4%, respectively."

Outlook

"As the board and management team continue to execute RCM's strategic plan to achieve progressively positive results, we are optimistic that our overall results for fiscal 2014 should improve compared to fiscal 2013. On a personal note, I have been contemplating retirement for the past few years. I've always wanted to retire at a time when all three business segments are positioned with strong leadership in place and are contributing together to the overall performance of the Company. I am extremely pleased to hand over leadership to Rocco Campanelli at this very exciting time in our history.  I'm confident that the Company will continue to grow and prosper under his leadership."

About RCM

RCM Technologies, Inc. is a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced information technology and engineering services.   RCM is an innovative leader in the delivery of these solutions to commercial and government sectors. RCM is also a provider of specialty healthcare services to major health care institutions and educational facilities. RCM's offices are located in major metropolitan centers throughout North America. Additional information can be found at www.rcmt.com .

The Statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995 and are subject to various risks, uncertainties and other factors that could cause the Company's actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," "believe," "plan," "seek," "could," "can," "should," "are optimistic that" or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, as well as our perceptions of historical trends, current conditions, expected future developments and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company's services, expected demand for our services and expectations regarding our revenues, the Company's ability to continue to utilize goodwill, to continue to increase gross margins, to achieve and manage growth, to develop and market new applications and services, risks relating to the acquisition and integration of acquired businesses, the ability of the Company to consummate acquisitions as to which it executes non-binding letters of intent, demand for new services and applications, timing of demand for services, industry strength and competition, initiatives to enhance stockholder value and general economic factors. Such statements are based on current expectations that involve a number of known and unknown risks, uncertainties and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties and other factors may emerge from time to time that could cause the Company's actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties and other factors described in documents filed by the Company with the Securities and Exchange Commission. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

RCM Technologies, Inc.
Condensed Consolidated Statements of Income 
(Unaudited)
 (In Thousands, Except Per Share Amounts)
     
  Thirteen Week Periods Ended
  December 28,
2013
December 29,
2012
Revenues $45,849 $37,019
Cost of services  34,055 26,920
Gross profit 11,794 10,099
Selling, general and administrative 9,263 8,401
Depreciation and amortization 282 368
Operating income before severance and other charges 2,249 1,330
Severance and other charges 4,728 --
Operating (loss) income (2,479) 1,330
Other (expense) income, net (42) 84
(Loss) income before income tax effect  (2,521) 1,414
Income tax (benefit) expense  (939) 385
Net (loss) income ($1,582) $1,029
     
Diluted net (loss) earnings per share data ($0.13) $0.09
     
  Fifty-Two Week Periods Ended
  December 28,
2013
December 29,
2012
Revenues $170,778 $145,817
Cost of services  126,417 106,102
Gross profit 44,361 39,715
Selling, general and administrative 35,514 33,166
Depreciation and amortization 1,111 1,321
Operating income before severance and other charges 7,736 5,228
Severance and other charges 5,181 --
Operating income 2,555 5,228
Other income, net 32 102
Income before income taxes  2,587 5,330
Income tax expense  597 2,103
Net income $1,990 $3,227
     
Diluted net earnings per share data $0.16 $0.26
     
RCM Technologies, Inc.
Summary Consolidated Selected Balance Sheet Data
 (In Thousands)
     
  December 28,
2013
December 29,
2012
Cash and cash equivalents  $9,317 $14,123
Accounts receivable, net $55,726 $43,706
Total current assets $72,704 $70,345
Total assets $86,524 $84,548
Total current liabilities $24,739 $25,063
Total liabilities $25,146 $25,776
Stockholders' equity $61,378 $58,772
Stockholder's equity less goodwill and intangible assets $51,617 $48,895
 
RCM Technologies, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In Thousands)
     
  Thirteen Week Periods Ended
  December 28,
2013
December 29,
2012
Net income ($1,582) $1,029
Adjustments to reconcile net income to cash provided by operating activities (548) 500
Changes in operating assets and liabilities    
Accounts receivable (1,418) (5,584)
Transit accounts receivable 1,432 (6,677)
Prepaid expenses and other current assets (636) (9)
Accounts payable and accrued expenses (1,502) 597
Transit accounts payable (1,872) 8,077
Accrued payroll and related costs 2,187 (1,478)
Income taxes payable (593) (339)
Total adjustments (2,950) (4,913)
Cash used in operating activities ($4,532) ($3,884)
     
Net cash used in investing activities (292) (197)
Net cash provided by (used in) financing activities 16 (12,016)
Effect of exchange rate changes 76 8
Decrease in cash and cash equivalents ($4,732) ($16,089)
     
     
  Fifty-Two Week Periods Ended
  December 28,
2013
December 29,
2012
Net income $1,990 $3,227
Adjustments to reconcile net income to cash provided by operating activities 703 2,253
Changes in operating assets and liabilities    
Accounts receivable (12,473) (4,693)
Transit accounts receivable 6,073 (6,981)
Prepaid expenses and other current assets 46 160
Accounts payable and accrued expenses 3,676 370
Transit accounts payable (8,052) 8,958
Accrued payroll and related costs 3,951 376
Income taxes payable 294 (106)
Total adjustments (5,782) 337
Cash used in operating activities ($3,792) $3,564
     
Net cash used in investing activities (1,322) (1,848)
Net cash provided by (used in) financing activities 290 (15,999)
Effect of exchange rate changes 18 (11)
Decrease in cash and cash equivalents ($4,806) ($14,294)

RCM Technologies, Inc. 2500 McClellan Avenue Pennsauken, NJ 08109 Tel: 856.356.4500 Fax: 856.356.4600 www.rcmt.com Corporate Contacts: Leon Kopyt Chairman, President & CEO Kevin D. Miller Chief Financial Officer

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 77

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading
Decoding the Insurance Agent Hunt in Hot Springs

Updated Category News Views 35

Look Beyond Just Rates When Selecting Your Agent When it comes to picking the right insurance agent in the charming enclave of Hot Springs, AR, it's not just about snagging the lowest rate. Victoria Payne, a seasoned pro from the Victoria Payne Agency, drills down on what actually counts in the HelloNation article she's featured in. It's about more than dollars and cents;...

Continue Reading
GAC Dominates with 8 Awards in Cutting-Edge Tech

Updated Category News Views 97

GAC's Moment in the Spotlight Wow, did ya hear about GAC grabbing eight shiny awards at the China-SAE Science and Technology gig? That ain't small potatoes, especially when you're bagging four first prizes. These fellas in Suzhou on October 28 sure showed they're not just playing in the sandbox but are ready to build the darn thing. There's power, and then there's GAC's...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 96

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
Are Shareholder Interests at Risk in These Deals?

Updated Category News Views 84

Potential Pitfalls in Pending Transactions In the tangled world of corporate deals, not every handshake benefits everyone around the table. This time, it's Surgery Partners, Range Resources, and Penske Automotive Group finding themselves under legal scrutiny. We'll dig into why Nasdaqq:SGRY, Nyse:RRC, and Nyse:PAG, might have some explaining to do. Whose Pockets Are...

Continue Reading
LeanDNA's APEX Awards Spotlight Supply Chain Innovators

Updated Category News Views 66

Shaking Things Up in Supply Chain with APEX Awards LeanDNA has just dropped their second annual APEX Awards on us, sending ripples through the world of supply chain management. The big reveal happened at the LeanDNA Manufacturing Excellence Summit in Austin, celebrating those who are pushing the envelope in logistics using cutting-edge technology. Award Categories and...

Continue Reading
HIMS Faces Class Action Over Alleged Privacy Violations

Updated Category News Views 66

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Continue Reading
Excellence Award Celebrates Medicilon-Revolution Partnership

Updated Category News Views 27

Breaking the 'Undruggable' Myth Out there in the trenches of drug discovery, this Medicilon and Revolution Medicines partnership has been stirring up some waves. Now, I ain't talking about your daily Wall Street hubbub, but a three-year grind that's led to something seriously noteworthy: turning the so-called 'undruggable' KRAS target into a real game-changer. Pan-KRAS...

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 121

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Trade Cases on Pizza Box Imports Set Industry Ablaze

Updated Category News Views 66

U.S. Takes Stand Against Unfair Import Practices Who knew pizza boxes could stir up such a fuss, huh? Well, here we are. The U.S. International Trade Commission (ITC) has sided with American pizza box manufacturers, waving the flag against those sneaky imports from China, Malaysia, and Turkey. According to the ITC, these imports are causing some real headaches for the...

Continue Reading

Top 5 Most Recently Viewed Articles

Amendments Approved by Baltic Horizon Fund Bondholders

Updated Category News Views 192

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Continue Reading
Sagimet Biosciences Shares Exciting First Quarter Highlights

Updated Category News Views 177

Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...

Continue Reading
Important Class Action for Lilium N.V. Shareholders to Join

Updated Category News Views 107

Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....

Continue Reading
Intellia Launches Pivotal Phase 3 Trial for NTLA-2002

Updated Category News Views 84

Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...

Continue Reading
Margot Black Unveils New Book: Transform Your Dreams Now

Updated Category News Views 120

Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...

Continue Reading